CVS Health Corporation

CVS

Healthcare Healthcare Plans

CVS Health Corporation’s revenue for fiscal 2025 (year ended December 2025) was $402.1 billion, up 7.85% from fiscal 2024.

Revenue
+5.37%
EPS
n/m
Free cash flow
+3,886.7%
Total debt
−7.83%

Quarter to September 2026, against a year earlier

86.50 2.00 −2.26%
Market cap
$113.4B
P/E
10.2×
Fwd P/E FY26e
12.8×
Dividend yield
3.01%
F-score
7/9
ROIC
7.44%
Net debt / EBITDA
3.6×
Payout ratio
0.3×

CVS Health Corporation 10-Q filed Nov 4, 2026

Fiscal Q3 2026 · Period ended Sep 30, 2026 · Filed · accepted 6:37 AM ET · Document on sec.gov · Filing index

What changed

Part I, Item 2, Management’s Discussion and Analysis, against the 10-Q filed Aug 5, 2026: 24 added · 7 removed · 39 modified; 23 with only figures updated; 1 moved without change

  1. Added · CVS Health’s Intention to Separate into Two Independent, Publicly Traded Companies

    On November 4, 2026, CVS Health announced its intention to separate into two independent, publicly traded companies in a transaction that is intended to be tax-free to CVS Health and its shareholders for U.S. federal income tax purposes. The planned separation will create two companies: a healthcare solutions company comprising Aetna, CVS Caremark, CVS Specialty, Oak Street Health and Signify Health, and a retail pharmacy and community healthcare company comprising retail pharmacy, mail pharmacy, MinuteClinic (including virtual care), and the Health100 technology services business. The healthcare solutions company, in the interim, will be referred to as CVS Health. The retail pharmacy and community healthcare company will be named CVS Pharmacy. The separation is expected to be completed in the first half of 2028, subject to customary conditions, including, among others, final approval by the CVS Health Board of Directors, effectiveness of a Form 10 registration statement filed with the SEC and receipt of customary confirmation that the separation is expected to be tax-free to CVS Health and its shareholders.